Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (26)

2020

  1. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

  2. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

2019

  1. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 188-201

  2. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003

  3. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

2018

  1. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox

    United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629

2017

  1. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2201-2211

  2. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype

    Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862

  3. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

2016

  1. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study

    PLoS Medicine, Vol. 13, Núm. 5

  2. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

    Digestive and Liver Disease, Vol. 48, Núm. 5, pp. 542-551

  3. Endoscopist characteristics that influence the quality of colonoscopy

    Endoscopy, Vol. 48, Núm. 3, pp. 241-247

  4. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

    BMC Medicine, Vol. 14, Núm. 1

  5. Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study

    Gut, Vol. 65, Núm. 11, pp. 1829-1837

2015

  1. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease

    International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373

2014

  1. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4

  2. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

    Cancer Causes and Control, Vol. 25, Núm. 8, pp. 985-997

2013

  1. Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test

    Mayo Clinic Proceedings

  2. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals

    Gastrointestinal Endoscopy, Vol. 78, Núm. 2

  3. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies

    Gastrointestinal Endoscopy, Vol. 77, Núm. 3